Effectiveness and Safety of Mirabek Sustained-release 50 mg Tablets in Korean Patients with Overactive Bladder: A Multicenter Observational Study at Tertiary General Hospitals
In this study, we looked at the effect of Mirabek, a generic medication for overactive bladder (OAB), in >4000 Korean patients treated in large hospitals. We found that Mirabek improved bladder symptoms such as urgency and frequent urination over 6 mo, with very few side effects. Most patients stayed on the treatment and reported feeling better, suggesting that this affordable medication can help more people manage their OAB effectively.
Authors
- Jongchan Kim (ORCID: https://orcid.org/0000-0002-0022-6689)
- Won Sik Jang (ORCID: https://orcid.org/0000-0002-9082-0381)
- Jee Soo Park (ORCID: https://orcid.org/0000-0001-9976-6599)
- Moon-Hwa Park
Institutions
- Yonsei University (KR)
- Severance Hospital (KR)
- Hanmi Pharmaceutical (South Korea) (KR)
- Yonsei University Health System (KR)
Publication Details
- Journal
- European Urology Open Science
- Published
- 2025-10-22
- DOI
- https://doi.org/10.1016/j.euros.2025.10.004
- Primary Topic
- Urinary Bladder and Prostate Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00